Skip to main content

In vitro and in vivo antidermatophytic activity of the dichloromethane-methanol (1:1 v/v) extract from the stem bark of Polyscias fulva Hiern (Araliaceae)



During the last decades, the number of people suffering from dermatophytoses has seriously increased, mainly due to the development of resistant strains of microorganisms to a range of formally efficient antibiotics. Polyscias fulva, a medium size tree which grows in the West Region of Cameroon is traditionally used for local application against dermatoses and orally against venereal infections. The dichloromethane-methanol (1:1 v/v) extract from the stem bark of Polyscias fulva was evaluated for its in vitro and in vivo antifungal activities.


The plant extract was prepared by maceration of its stem bark powder in CH2Cl2-MeOH (1:1 v/v). The extract obtained was successively partitioned in hexane, ethyl acetate and n-butanol. Phytochemical screening was performed using standard methods. In vitro antidermatophytic activity was assayed by the well diffusion and broth microdilution methods. The degree of dermal irritation of the crude extract was determined in guinea pigs using the occluded dermal irritation test method. The in vivo antidermatophytic activity of the extract-oil formulation (1.25, 2.5 and 5% w/w concentrations) was evaluated using Trichophyton mentagrophytes- induced dermatophytosis in a guinea pigs model.


Phytochemical screening indicated that, the crude extract, ethyl acetate, n-butanol and residue fractions contain in general saponins, tannins, alkaloids, anthraquinones and phenols while the hexane fraction contains only alkaloids. The ethyl-acetate, n-butanol and residue fractions displayed higher antifungal activities (MIC = 0.125-0.5 mg.mL-1) against eight dermatophytes as compared to the crude extract (MIC = 0.5-1 mg.mL-1). This latter appeared to have slight perceptible erythema effects on guinea pigs as the primary irritation index (PII) was calculated to be 0.54. In vivo, the antidermatophytic activities of the extract-oil formulations were dose-dependent. Griseofulvin-oil 5% at 0.01 g/kg and formulated extract-oil (5%) at 0.1 g/kg eradicated the microbial infection after thirteen and fourteen days of daily treatment respectively.


The results of preclinical in vitro and in vivo evaluations indicate that the extract-oil formulation at 5% may constitute an alternative means to alleviate fungal infections caused by dermatophytes.

Peer Review reports


Dermatophytic infections, often referred to as ringworm and tinea are known to cause universal affliction of humans and their domestic animals. Dermatophytes colonize the skin, nails, and hair of human populations together with similar infections on animal hides, hooves, feathers, beaks, and other dermal appendages [1]. Dermatophytes thus affect keratinous tissues of humans and other vertebrates, causing superficial infections. These microorganisms belong to three genera: Trichophyton, Microsporum and Epidermophyton[1]. Dermatophytoses generally comply with topical antifungal therapy, although local therapy may be inappropriate for extensive infections or for infections affecting the nails or scalp. In recent years, a number of antifungal agents have been introduced into clinical practice including griseofulvin, terbinafine, itraconazole, fluconazole, and more recently voriconazole [1, 2]. However, their spectrum of action is narrow and also many of them have adverse side effects [3, 4]. The treatment of these infections is often long and expensive, and there have been increasing reports of antifungal resistance [5]. Thus, there is a need for the search for new sources of antidermatophytic substances. Herbal medicines have been widely used and form an integral part of primary health care in many countries [6], and may constitute a reservoir of new antifungal substances. According to World Health Oganisation, medicinal plants would be the best source of a variety of drugs [7]. About 80% of the total population in developing countries relies on traditional medicines based on plant products [8]. Unfortunately, their traditional use remains empirical, doses and durations of treatment for example are not clearly defined. There is therefore need for chemical and pharmacological studies that may help to achieve the standardization of such treatment. This explains why numerous studies have been conducted on various medicinal plant extracts with the hope of discovering new and more efficient antifungal compounds.

Among these plants is Polyscias fulva, a medium size tree which grows in the tropical forests of West and Central Africa, and is traditionally used to treat malaria and mental illness [9]. In Cameroon, a decoction of the stem bark of Polyscias fulva bark is traditionally taken orally against venereal infections [10]. Furthermore, its stems and leaves are pounded and used for local application against dermatoses. Phytochemical analyses revealed the presence of triterpenes glycosides [11] and others compounds like Lichexantone, 3-o-β-D-glucopyranosyl-stigmasterol, 3-α-L-arabino-pyranosyl-hederagenin (cauloside A), α-hederin and kalopanax-saponin B [12] from the aerial part of the plant. Based on traditional uses of this plant, we believe that the extract could possess antidermatophytic proprieties and an oil-extract formulation may be effective in the treatment of dermatophytic infection. Several similar studies have been conducted and showed the relative effectiveness of such preparations. For example, we can mention the work on the essential oil of Chenopodium ambrosioides [13], Zataria multiflora [14] and Eucalyptus camaldulensis [15]. The main difficulty of such a study is the induction of dermatophytosis in a suitable animal model.

To the best of our knowledge, no work exists on the antidermatophytic activity of this plant. Thus, the present study was undertaken to evaluate the in vitro and in vivo antifungal activities of the dichloromethane-methanol (1:1v/v) extract from the stem bark of Polyscias fulva.


Plant material

The stem bark of Polyscias fulva (Hiern) was collected in April 2008 at Bazou (Nde Division, West Region, Cameroon). Botanical identification was done at the Cameroon National Herbarium in Yaoundé by Mr Tadjouteu Fulber and where a voucher specimen was kept under the reference number 43546/HNC.


Tests were performed on eight dermatophytes: four clinical isolates including Microsporum audouinii from the “Centre Pasteur” of Yaoundé, Trichophyton rubrum from the “Centre Pasteur” of Paris, Trichophyton ajelloi and Trichophyton equinum from “Ecole Nationale Vétérinaire d’Aford” in France; four strains including Trichophyton mentagrophytes (E 1425), Trichophyton terrestre (E 1501), Trichophyton Microsporum gypseum (E 1420) and Epidermophyton floccosum (E 1423), all from “Ecole Nationale Vétérinaire d’Aford” in France. The strains have been maintained in the refrigerator at 4°C on agar slant as previously described [16].


The dermal irritation test and the in vivo Antidermatophytic activity of the crude extract were performed using adult guinea pigs of both sexes (400 ± 50 g) bred in the Animal House of the Department of Biochemistry, University of Dschang, Cameroon. The animals were fed with standard guinea pig feed and water ad libitum throughout the experimental period. Animals were exposed to natural room temperature (22±2°C) and were handled according to standard protocols for the use of laboratory animals [17, 18]. Animals were randomly selected and caged individually or in a group, depending on the type of assay, for 5 days prior to the start of the test for acclimatization to the test conditions. They were also randomly assigned to control and test groups.

Preparation of plant extract and fractionnation

The stem barks of P. fulva were dried at room temperature (20–24°C) for fifteen days and powdered to coarse particles. Four kilograms of powder were macerated in 10 L of the dichloromethane-methanol (Merck) (1:1 v/v) mixture for two days with frequent stirring and this process was repeated twice on the residue. After filtration, using Wathmann filter paper N° 1, the filtrate was evaporated to dryness under vacuum at 45°C using a rotary evaporator (Büchi R200). The obtained crude extract (263 g) obtained was then partitioned successively in hexane, ethyl acetate and n-butanol to obtain the hexane (27.25 g), ethyl acetate (23.77 g), n-butanol (16 g) and residue (195.98 g) fractions after solvent evaporation. The percentages of crude extract and fractions are reported with respect to the plant material and crude extract respectively. The number of compounds in the crude extract and fractions were estimated based on their thin-layer chromatography (TLC) profiles. Mixtures of ethyl acetate-methanol were used as elution as follow: 8:2 for the crude extract and ethyl acetate fraction; 10:1 for hexane fraction, 9:3 for n-butanol fraction and 6:4 for the residue fraction. Spots and bands were visualized by UV radiation (254 and 366 nm) and by spraying with 50% (v/v) sulphuric acid reagent followed by heating at 100°C.

Phytochemical screening

The phytochemical analysis of the crude extract and its fractions were carried out using standard methods [19]. The plant material was screened for the presence of different classes of compounds including alkaloids, flavonoids, sterols, triterpenes, coumarins, anthraquinones, tannins, anthocyanins, saponins and phenols.

In vitro Antidermatophytic activity

Preparation of dermatophyte inocula

The spore suspensions used for the inoculation were prepared from a 15 days old cultures on Sabouraud Dextrose Agar (Conda, Madrid, Spain) culture medium. The culture surfaces were gently scraped and placed in test tubes containing 10 mL of sterile saline; then homogenized by end-to-end mixing for 5 minutes and filtered. The absorbances of the spore suspensions (filtrates) were read at 530 nm and adjusted with sterile distilled water between 0.15 and 0.17 to match 0.6 × 106 -1.4 × 106 CFU.mL-1[20].

Antidermatophytic activity using the well diffusion method

The well diffusion test was carried out as previously described [21]. Briefly, stock solutions of the extracts (crude extract and fractions) were prepared in 5% v/v aqueous dimethyl sulphoxide (DMSO, Fisher Chemicals) at a concentration of 100 mg.mL-1. Glass bottles, each containing 19.8 mL of sterile, matten Sabouraud Dextrose Agar medium were maintained in a water bath set at 40°C (to prevent solidification of the medium) and then inoculated aseptically with 0.2 mL of a given spore suspension followed by thorough mixing. Each 20 mL mixture was poured into a sterile Petri dishe (90 mm of diameter) and allowed to solidify. A wells of 6 mm in diameter was then made in the middle of SDA plate and filled with 50 μl of an extracts prepared at 50 mg.mL-1. The inoculated plates were then incubated at 30°C for five days. The susceptibility was recorded by measuring the diameter of the clear zone of growth inhibition on the agar surface around each well. All the experiments were repeated thrice: Griseofulvin (Merck, Darmstadt, Germany) at 10 μg/well was used as positive control while the dilution solution (5% (v/v) aqueous DMSO) served as negative control.

Antidermatophytic activity using broth microdilution method

The broth microdilution method [22] was used to determine the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of the tested substances using 96 well microplates (Nunclon, Roskilde, Danmark). Two-fold serial dilutions of the extract (Concentration range: 8–0.0625 mg.mL-1), fractions (Concentration range: 1–0.0078 mg.mL-1) and reference drug (Concentration range: 0.1-0.00078 mg.mL-1) were performed in Sabouraud Dextrose Broth (SDB) in a total volume of 200 μL per well. Each well contained 100 μL of the test substance at a particular concentration, and 100 μL of the fungal spore suspension corresponding to approximately 104 CFU.mL-1. The microwell plates were covered and incubated at 30°C for five days on a plate shaker (Flow Laboratory, Germany) at 300 rpm. Fungal growth in each well was determined by observing and comparing the turbidity of the test wells to that of the positive and negative controls. The MIC was the lowest concentration of the test substance that prevented visible growth of the microorganisms.

The minimum fungicidal concentration (MFC) values were determined by subculturing 50 μL aliquots of the preparations, which did not show any visible growth of the micro-organisms during MIC determinations. These preparations were further incubated at 30°C for five days on the plate shaker at 300 rpm. Microbial growth in each well was determined by observing and comparing the turbidity of test wells to that of the positive and negative controls. The MFC was the lowest concentration of the test substances that prevented visible growth of the microorganisms in the sub-cultures. For every experiment, sterility controls (5% v/v aqueous DMSO, medium, inocula and griseofulvin) were included. All the experiments were performed in triplicates.

In vivo study

Ethical statement

All studies involving animals were conducted according to the ethical guidelines of the Committee for Control and Supervision of Experiments on Animals (Registration no. 173/CPCSEA, dated 28 January, 2000), Government of India, on the use of animals for scientific research.

Skin irritation test

The degree of dermal irritation of the dichloromethane-methanol (1:1v/v) extract from the stem bark of Polyscias fulva was determined in guinea pigs using the occluded dermal irritation test method [23]. Twelve guinea pigs (six males and six females) were used and each animal served as its own control. They were divided into two groups (group 1 and group 2) of six animals each (3 males and 3 females) and treated with water-moistened extract and oil-moistened extract respectively. On day 0, fur was shaved from the back of each animal, about 6 cm2 on both sides. The left side served as a negative control, while the right one served as a test site. The guinea pigs were caged individually for 24 h. On day 1, the extract (0.5 g) moistened with distilled water was evenly applied to the test sites of group 1 animals and the skin was covered with a gauze patch, plastic sheet and a non-irritant adhesive plaster. The control sites were treated with distilled water and covered as above. The animals of group 2 were treated with oil-moistened extract in the same manner as above. Palm kernel oil was used and also served as the negative control for the group 2 experiment.

After 24 h of exposure, the coverings were removed and the test site rinsed with distilled water and dried. The animals were examined for the presence of erythema and edema according to the Draize dermal irritation scoring system (0, no erythema or no edema; 1, barely perceptible erythema or edema; 2, well defined erythema or slight edema; 3, moderate to severe erythema or moderate edema; 4, severe erythema or edema) at grading intervals of 1, 24, 48 and 72 h [24].

The primary irritation index (PII) was calculated by dividing the sum of erythema and edema scores of the grading intervals by the number of grading intervals (4). The extract was then classified according to the Draize method of classification using the PII scoring method as mildly irritant (PII< 2), moderately irritant (2 ≤PII≤ 5), and severely irritant (PII>5).

In vivo antidermatophytic activity

This experiment was carried out using the crude extract. The fungal inoculum was prepared as described above in the section on in vitro antidermatophytic activity.

Dermal infection of animals

Both male and female guinea pigs (350-450 g) were used. The fur from the back of each guinea pig was shaved (approximately 16 cm2) and 50 μL of a suspension of T. Mentagrophytes spores was inoculated to a surface of about 4 cm2 area (previously lightly abraded with sandpaper) within the shaved zone [20, 25]. Animals were randomly assigned to different treatment groups. For each sex, there were seven groups of three animals each. Evidence of infection was revealed by direct observation of the infected area, followed by agar culture of scrapings from the area, and microscopic observation of the resulting fungi from the scrapings.

Treatment of infected animals

Animals were treated by dermal application of the test substance which started on the sixth day after animal infection and was continued daily (each morning). All animals except those of group 1 were infected and treated (Table 1).

Table 1 Infection and treatment of guinea pigs

Clinical surveillance of treatment

Clinical response was monitored by assigning a score between 0 and 4 to each infection site: 1 (for flakinsg skin with mild inflammation); 2 (for slight lesions with moderate inflammation); 3 (for moderate lesions with severe inflammation) and 4 (for severe inflammation plus crust formation). The results were expressed as the percentage reduction in mean lesion score at the time when placebo-treated (group 3) animals showed maximal severity (lesion score 4) [26].

The degree to which the animals complied with treatment was estimated by culturing skin scrapings and fur on Sabouraud Dextrose Agar supplemented with actidione (Conda), for recovery of viable T. Mentagrophytes cells. These scrapings and fur were collected from the active border of the infection site every two days [27]. The cultures were incubated for 15 days at 28°C. The results were recorded in terms of percentage culture recovery of T. Mentagrophytes of the infected site [14].

% Culture recovery = Total number of sites showing presence of dermatophytes Total number of infection sites × 100

Statistical analysis

Data on irritation are presented as visual scores based on Draize method of erythema and edema-grading system and PII was calculated, whereas the inhibition diameters of crude extract and fractions were expressed as the mean ± standard deviation. The Waller-Duncan test was used to compare the means for the different substances tested, at 5% significance level.


Phytochemical screening of extract and fractions

The phytochemical screening revealed that all the classes of compounds (saponins, tannins, alkaloids, anthraquinone and phenols) present in the crude extract were found in the ethyl acetate fraction (Table 2). The hexane fraction had only alkaloids. The n-butanol and residue fractions had almost the same composition except that anthraquinones were present in n-butanol fraction, while alkaloids were in the residual fraction.

Table 2 Physical characteristics and phytochemical analysis of crude extract of Polyscias fulva stem bark and its fractions

In vitro antidermatophytic assay

As revealed by the well diffusion method, the n-hexane fraction was almost inactive on all the tested microorganisms except E. floccosum. All the microorganisms appeared to be sensitive to the active substances with T. mentagrophytes, T. ajelloi and M. audouinii being the most sensitive (Table 3). Fractionation did not significantly increase antidermatophytic activities. These results were globally confirmed by the microdilution method for determination of MIC and MFC (Table 4), although on some species, fractions were more active. The MFC/MIC ratios were less than or equal to 2, indicating a possible fungicidal effect of the extract and its fractions.

Table 3 Diameter of the inhibition zones (mm) of CH 2 Cl 2 -MeOH (1:1v/v) crude extract and fractions of the stem bark of Polyscias fulva
Table 4 Minimum Inhibitory Concentration (MIC in mg.mL -1 ) and Minimum Fungicidal Concentration (MFC in mg.mL -1 ) of CH 2 Cl 2 -MeOH (1:1v/v) extract and fractions of the stem bark of Polyscias fulva

In vivo Antidermatophytic assay

Only infected animals were used in this assay. Up to the sixth day of treatment, lesions increased continuously in all the groups. From the 8th day, the intensity of lesions started dropping in the treated groups in a dose-dependent manner (Figures 1 and 2). The Griseofulvin-oil (5%) and extract-oil (5%) mixtures had comparable effects, eradicating surface lesions after 13 and 14 days of treatment respectively. However, the other doses gradually overcome the infection from the 17th day of treatment. Simultaneously, lesions continued to increase in the untreated groups (negative control and the vehicle-treated group), indicating the non-therapeutic effect of the vehicle. These results corroborate the percentage culture recovery experiment as there were no more fungal cells at the infection sites from the 14, 15, 17 and 19th days of treatment for griseofulvin-oil (5%), extract-oil at 5%, 2,5% and 1,25% respectively (Figure 3).

Figure 1

Evolution of lesion scores during treatment of infected guinea pigs: females (1a) and males (1b). G: Griseofulvin-oil; KPOC: Palm Kernel oil control; NC: Negative control; SC: Simple control (Non infected or non treated).

Figure 2

Comparative illustration of the evolution of the infection during treatment of infected guinea pigs with P. fulva extract-oil. 1: Uninfected animal. 2: Infected untreated animal. 3: Infected animal treated with 0.1 g/kg of palm Kernel oil. 4: Infected animal treated with 0.01 g/kg of griseofulvin-oil at 5%. 5: Infected animal treated with 0.1 g/kg of extract-oil at 1.25%. 6: Infected animal treated with 0.1 g/kg of extract-oil at 2.5%. 7: Infected animal treated with 0.1 g/kg of extract-oil at 5%.

Figure 3

Evolution of the percent culture recovery during treatment of infected guinea pigs: females (3a) and males (3b). G: Griseofulvin-oil; KPOC: Palm Kernel oil control; NC: Negative control; SC: Simple control (Non infected or non treated).

Skin irritation test

Group 1 animals did not show observable edema while barely perceptible erythema effects (PII = 0.54) were evident in guinea pigs of this group (Figure 4). Neither visible erythema nor edema were observed in the guinea pigs of group 2 (PII = 0.00). These results indicate that the use of palm kernel oil as a vehicle is preferable to water. The time course of recovery from irritation is depicted in Figure 5. Scores of erythema following 1 and 2 h after the opening of the patch were similar in intensity. However, the erythema score had sharply decreased and came to zero at the 72 h reading in group 1 (Figure 5). There was no erythema or edema observed on the control sites of all guinea pigs.

Figure 4

Illustration of the irritant effect of Polyscias fulva extract moistened with distilled water.

Figure 5

Degree of irritation and it trends of change since opening of the patch 24 h after dermal application of 0.5 g of dichloromethane-methanol (1:1v/v) extract from the stem bark of Polyscias fulva.


Antidermatophytic activity

Dermatophytes are closely related fungi which induce dermatophytosis. Treatment with topical fungicidal allylamines is more efficient than with fungistatic azoles [28]. Although not life threatening, dermatophytosis are difficult to eradicate, particularly in low income countries, due to the non-accessibility to efficient drugs and ignorance. In these countries, these diseases are mostly treated using medicinal plants. Herbal medicines have been important sources of bioactive substances belonging to diverse chemical groups [29]. The phytochemical screening of the crude extract of P. fulva and its fractions revealed the presence of saponins, tannins, alkaloids, anthraquinone and phenols that can explain their antidermatophytic activities. Individual activities of these compounds have been demonstrated [29]. Also, from our previous work, the antidermatophytic activities of triterpenes [30], essential oil of Ageratum houstonianum[31] and the volatile fraction of Cupressus lusitanica, constituted of monoterpens, sesquiterpens and triterpens [32], were reported. The n-hexane fraction was almost inactive, indicating that the active principle may not belong to the family of alkaloid.

Trichophytosis induced in guinea pigs is a well-established predictive model for testing topical antifungal agents [25]. This model was used in this study and permitted to show that the crude extract of P. fulva possesses in vivo antifungal activity against a virulent strain of T. mentagrophytes. Irrespective of sex, the extract-oil formulation at 5% was able to cure infected animals after fourteen days of treatment while griseofulvin produced the same effect after thirteen days. These results show that, this formulation can be used as a substitute or an alternative to the use of griseofulvin to cure dermatophytosis. It can therefore be a potent candidate for the elaboration of a phytomedicine. Similar results have been reported on the antidermatophytic action of a 1% oil-petroleum gelly formulation of the essential oil of Chenopodium ambroisoides which cured Trichophyton mentagrophytes- induced dermatophytosis in guinea pigs in 15 days [13]. Also similar effects have been reported on the extract-cream formulation of Zataria multiflora[14] and Eucalyptus camaldulensis[15].

In dermatophytic infections as observed in this study, inflammatory responses are usually characterized by a greater degree of redness and scaling at the edges of the lesions, or occasionally, blister formations [28]. This is often accompanied by mild irritation though, could be more severe with some types of fungal infection. During inflammation, reactive oxygen species and free radicals with many physiological and pharmacological adverse effects, including skin irritation are produced [33]. The phenols and tannins, identified in the P. fulva extract, are known for their ability to protect cells against reactive oxygen species and free radical-induced toxicity [34].

Skin irritation test

The irritation test revealed a negligible irritant effect of the extract at a high dose (0.5 g) on guinea pig’s skin. The low level of erythema observed quickly decreased after the opening of the occlusion. This can be attributed to the occlusion effect of the extract; a phenomenon known to boost phase I or the vascular event of an inflammatory response [35]. Occurrence of phase II or the cellular event of the inflammatory process was not evident in our study since there were no observable changes in the skin morphology of the guinea pigs. This confirms the assertion that the extract would have only a negligible irritation potential [36, 37]. Similar results have been reported on the skin irritation test of an 80% methanol extract of the leaf of Dodonaea viscose in rabbits where the primary irritation index was 0.45 [35]. The fact that neither erythema nor edema persisted in the guinea pigs could lend support to the fact that this plant extract is safe at the indicated dose. Also the absence of these clinical signs in the palm kernel oil-treated group suggests that use of this oil as a vehicle for administering this extract, is safe.


This study demonstrates that the crude dichloromethane-methanol (1:1 v/v) extract from the stem bark of Polyscias fulva possesses antidermatophytic properties without irritation effects. These results may justify the use of Polyscias fulva in the traditional medicine to cure dermatoses. Besides, palm kernel oil has been demonstrated to be a good vehicle. The oil-extract of Polyscias fulva may be a possible candidate for the standardization of an antidermatophytic phytomedicine or for the isolation of pharmacologically active antifungal agents.


  1. 1.

    Weitzman I, Summerbell RC: The Dermatophytes. Clin Microbiol Rev. 1995, 8: 240-259.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Ananth BD, Maheswara U, Reddy C: Antimicrobial activity of Methanol Extract of Oxystelma esculentum. J Pharm Sci Technol. 2010, 2: 119-123.

    Google Scholar 

  3. 3.

    Lorougnon F, Heron P, Therizol M, Kanga J, Djeha D, Yoboue P, Boussou D: Efficacité clinique de la naftifine dans le traitement des dermatomycoses. Médecine d’Afrique noire. 1991, 38: 707-714.

    Google Scholar 

  4. 4.

    Sorberon JR, Sgariglia MA, Sampietro DA, Quiroga EN, Vattuone MA: Antibacterial activity of plant extracts from North-western Argentina. J Appl Microbiol. 2007, 102: 1450-1461. 10.1111/j.1365-2672.2006.03229.x.

    Article  Google Scholar 

  5. 5.

    Ghannoum AM, Rice BL: Antifungal agent: mode of action, mechanisms of resistance and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev. 1999, 12: 501-517.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Akiniyemi KO, Oladapo O, Okwara CE, Ibe C, Fasure KA: Screening of crude extracts of six medicinal plants used in south-west Nigerian unorthodox medicine for anti-methicillin resistant- Staphylococcus aureus activity. Complement Alt Med. 2005, 5: 5-8. 10.1186/1472-6882-5-5.

    Article  Google Scholar 

  7. 7.

    Santos PRV, Oliveira ACX, Tomassini TCB: Controle microbiógico de produtos fitoterápicos. Rev Farm Bioquím. 1995, 31: 35-38.

    Google Scholar 

  8. 8.

    Nascimento GGF, Locatelli J, Freitas PC, Silva GL: Antibacterial activity of plants extracts and phytochemical on antibiotic-resistant bacteria. Braz J Microbiol. 2000, 31: 247-256.

    Google Scholar 

  9. 9.

    Ndaya TJ, Chifundera K, Kaminsky R, Wright AD, Konig GM: Screening of African medicinal plants for antimicrobial and enzyme inhibitory activity. J Ethnopharmacol. 2002, 80: 25-27. 10.1016/S0378-8741(01)00409-3.

    Article  Google Scholar 

  10. 10.

    Focho DA, Ndam WT, Fonge BA: Medicinal plants of Aguambu – Bamumbu in the Lebialem highlands, southwest province of Cameroon. Afr J. Pharm Pharmaco. 2009, 3: 001-013.

    Google Scholar 

  11. 11.

    Bedir E, Toyang NJ, Khan IA, Walker LA, Clark AM: A new dammarance-type triterpene glycoside from Polyscias fulva. J Nat Prod. 2001, 64: 95-99. 10.1021/np0003589.

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Mitaine-Offer AC, Tapondjou LA, Lontsi D, Sondengam BL, Choudhary MI, Atta-Ur-Rahman L-DMA: Constituents isolated from Polyscias fulva. Biochem syst ecol J. 2004, 32: 607-610. 10.1016/j.bse.2003.10.008.

    CAS  Article  Google Scholar 

  13. 13.

    Aghel N, Moghimipour E, Ameri A: Characterization of an anti-dermatophytic cream from Zataria multiflora Boiss. Iran J Pharm Sci. 2007, 3: 77-84.

    Google Scholar 

  14. 14.

    Moghimipour E, Ameri A, Saudatzadeh A, Salimi A, Siahpoosh A: Formulation of an antidermatophytic cream from hydro-alcoholic extract of Eucalyptus camaldulensis leaves. Jundishapur J Nat Pharm Prod. 2009, 4: 32-40.

    Google Scholar 

  15. 15.

    Thirumalai T, David E, Viviyan SV, Therasa EEK: Restorative effect of Eclipta alba in CCl4 induced hepatotoxicity in male albino rats. Asian Pac J Trop Med:. 2011, 304-307.

    Google Scholar 

  16. 16.

    Salie F, Eagles PFK, Leng HMJ: Preliminary antimicrobial screening of four South African asteraceae species. J Ethnopharmacol. 1996, 52: 27-33. 10.1016/0378-8741(96)01381-5.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    OECD guidelines for testing of chemicals: Repeated dose dermal toxicity: 21/28-day study. OECD guideline for testing chemicals. 1981, 410: 1-8.

    Google Scholar 

  18. 18.

    OECD guidelines for testing of chemicals: Acute dermal toxicity. OECD guideline for testing chemicals. 1987, 402: 1-7.

    Google Scholar 

  19. 19.

    Harbone SB: Baxter H (1996) Phytochemical dictionary. 1996, London: A handbook of bioactive compounds from plants. Taylor Francis,

    Google Scholar 

  20. 20.

    Iwata K, Yamashita T, Vehara H: In vitro and in vivo activities of piritetrate (M.372), a new antidermatophyticthiocarbamate. Antimicrob agents ch. 1989, 33: 2118-2125. 10.1128/AAC.33.12.2118.

    CAS  Article  Google Scholar 

  21. 21.

    Rios JL, Recios MC, Willar A: Screening method for natural product with antimicrobial activity: a review of literature. J Ethnopharmacol. 1988, 23: 127-149. 10.1016/0378-8741(88)90001-3.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Gulluce M, Sokmen M, Dafera D, Aga RG, Ozkan F: In vitro antibacterial, antifungal and antioxidant activities of herbal parts and callus cultures of Satureja hortensis L. J Agric Food Chem. 2003, 51: 3958-3965. 10.1021/jf0340308.

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Auletta CS, CRC: From Acute, subchronic toxicology. Handbook of toxicology. 1995, London: Derelanko and Hollinger, 51-162.

    Google Scholar 

  24. 24.

    Draize JH: (1959) The appraisal of chemicals in foods, drugs and cosmetics. 1959, The association of food and drugs officials of the United States: Austin Texas USA,

    Google Scholar 

  25. 25.

    Polak A: Experimental models in antifungal chemotherapy. Mycoses. 1998, 41: 1-30.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Wahabe S, Tandon RN, Jacob Z, Chandra B, Srivastava OP: Comparative in vitro and in vivo effect of lactones and arnabine on Trichophyton mentagrophytes and Candida albicans. Indian J Med Res. 1982, 76: 77-82.

    Google Scholar 

  27. 27.

    Cray SM: Douglas: Mycology for clinical laboratories. 1979, Virginia: Reston publishing company inc,

    Google Scholar 

  28. 28.

    Hainer BL: Dermatophyte Infections. Am Fam Physician. 2003, 67: 101-109.

    PubMed  Google Scholar 

  29. 29.

    Cowan MM: Plant products as antimicrobial agents. Clin Microbiol Rev. 1999, 12: 564-582.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Kuiate JR, Mouokeu S, Wabo HK, Tane P: Antidermatophytic triterpenoids from Syzygium jambos (L.) Alston (Myrtaceae). Phytother Res. 2007, 21: 149-152. 10.1002/ptr.2039.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Njateng GSS, Kuiate JR, Gatsing D, Tamokou JD, Mouokeu S, Kuete V: Antidermatophytic activity and dermal toxicity of essential oil from the leaves of Ageratum houstonianum (Asteraceae). J Biol Sci. 2010, 10: 448-454.

    Article  Google Scholar 

  32. 32.

    Kuiate JR, Bessière JM, AmvamZollo PH, Kuate SP: Chemical composition and antidermatophytic properties of volatile fractions of hexanic extract from leaves of Cupressus lusitanica Mill from Cameroon. J Ephnopharmacol. 2006, 103: 160-165. 10.1016/j.jep.2005.07.022.

    CAS  Article  Google Scholar 

  33. 33.

    Kishore N, Chansouria JPN, Dubey NK: Antidermatophytic action of the essential oil of Chenopodium ambrosioides and an ointment prepared from it. Phytother res. 1996, 10: 453-455. 10.1002/(SICI)1099-1573(199608)10:5<453::AID-PTR874>3.0.CO;2-A.

    CAS  Article  Google Scholar 

  34. 34.

    Zielinska M, Kostrzewa A, Ignatowicz E, Budzianowski J: The flavonoids, quercetin and isorhamnetin 3-O-acylglucosides diminish neutrophil oxidative metabolism and lipid peroxidtion. Acta Biochim Pol. 2001, 48: 183-189.

    CAS  PubMed  Google Scholar 

  35. 35.

    Kefale T, Tsige GM, Kaleab A, Ephrem E: Toxicity studies on dermal application of plant extract of Dodonaea viscose used in Ethiopian traditional medicine. Phytotherapy research J. 2010, 24: 60-69. 10.1002/ptr.2869.

    Article  Google Scholar 

  36. 36.

    Derelanko MJ, Hollinger MA: (1995) Handbook of toxicology. 1995, Boca Raton, Florida: CRC press,

    Google Scholar 

  37. 37.

    Gerberick GF, Vassalo DJ, Bailey RE, Chaney JG, Morrall SW, Lepoittevin JP: Development of a peptide reactivity assay for screening contact allergens. Toxicol Sci. 2004, 81: 332-343. 10.1093/toxsci/kfh213.

    CAS  Article  PubMed  Google Scholar 

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:

Download references


We wish to express our gratitude to the Medical Microbiology laboratory, Pasteur Centre, Yaoundé, Cameroon, and to the “Ecole Nationale Vétérinaire d’Aford” in France, for their kind co-operation and technical assistance during the research.

Author information



Corresponding author

Correspondence to Jules-Roger Kuiate.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

GSSN is the field investigator and have drafted the manuscript. DG supervised the work and contributed to drafting the manuscript. JRK designed the study, supervised the work and finalized the manuscript. RSM contributed to the phytochemical studies. PKL contributed to the field work and corrected the language of the manuscript. All authors read and approved the final manuscript.

Authors’ original submitted files for images

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Njateng, G.S.S., Gatsing, D., Mouokeu, R.S. et al. In vitro and in vivo antidermatophytic activity of the dichloromethane-methanol (1:1 v/v) extract from the stem bark of Polyscias fulva Hiern (Araliaceae). BMC Complement Altern Med 13, 95 (2013).

Download citation


  • Antidermatophytic activity
  • Polyscias fulva
  • Extract-oil formulation
  • Irritation test
  • Primary irritation index
  • Guinea pigs